Boothbay Fund Management, LLC Intercept Pharmaceuticals, Inc. Transaction History

Boothbay Fund Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$9.17 - $19.29 $8.53 Million - $17.9 Million	930,155 Added 8018.58%	941,755 $10.4 Million
Q3 2022 Nov 14, 2022	SELL	$12.21 - $19.7 $58,351 - $94,146	-4,779 Reduced 29.18%	11,600 $162,000
Q2 2022 Aug 15, 2022	BUY	$11.23 - $19.59 $183,936 - $320,864	16,379 New	16,379 $226,000
Q1 2022 May 16, 2022	SELL	$13.37 - $17.79 $271,330 - $361,030	-20,294 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$14.28 - $19.53 $289,798 - $396,341	20,294 New	20,294 $331,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.